Testing cancer drugs using patient-derived organoid models

PREDICTIVE DRUG TESTING IN ORGANOID MODELS

NIH-funded research Leidos Biomedical Research, INC. · NIH-11195485

This study is looking at how well different cancer drugs work using tiny lab-grown versions of tumors made from real patient samples, to help find the best treatments for individual patients based on their unique tumor characteristics.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLeidos Biomedical Research, INC. NIH-funded
Lab location1 site (Frederick, United States)
Project IDNIH-11195485 on NIH RePORTER

What this research studies

This research investigates how effective various approved and experimental cancer drugs are by using organoid models created from actual patient tumor tissues. By employing high-throughput screening techniques, the study aims to identify which tumors respond to specific drugs and to understand the mechanisms behind these responses. Additionally, it will explore how genetic changes in tumors affect drug efficacy and resistance, providing insights that could lead to more personalized cancer treatments.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients with specific types of cancer who have tumor tissues available for organoid development.

Not a fit: Patients without tumor tissue samples or those with cancers not represented in the organoid models may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for patients based on their unique tumor characteristics.

How similar studies have performed: Other research has shown promise in using organoid models for drug testing, indicating that this approach could be effective.

Where this research is happening

Frederick, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer AgentsCancer DrugNeoplastic Disease Chemotherapeutic Agents
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.